法國(guó)國(guó)家衛(wèi)生研究所(INSERM)2024年招聘博士后（1型糖尿病的新型調(diào)節(jié)性T細(xì)胞療法）
法國(guó)國(guó)家健康與醫(yī)學(xué)研究院（法文為：Institut national de la santé et de la recherche médicale），簡(jiǎn)稱(chēng)“Inserm”，成立于1964年，是一所總部位于法國(guó)巴黎的國(guó)家級(jí)公共科學(xué)和技術(shù)研究機(jī)構(gòu)，其前身是成立于1941年的法國(guó)國(guó)家衛(wèi)生研究院，由法國(guó)衛(wèi)生部和研究部共同管理。Inserm是法國(guó)唯一一個(gè)完全致力于人類(lèi)健康的公共研究組織，參與從研究到治療的全過(guò)程，其宗旨通過(guò)增進(jìn)對(duì)生命和疾病的知識(shí)、創(chuàng)新治療方法和公共衛(wèi)生研究，促進(jìn)全人類(lèi)健康。
Postdoctoral position for EU project ARTiDe: A novel regulatory T celltherapy for type 1 diabetes
Employer
French National Institute for Health Research (INSERM)
Location
Paris, Ile-de-France (FR)
Salary
The postdoctoral salary will be according to experience following INSERM regulation.
Closing date
19 Aug 2024
This project is funded via the European consortium ARTiDe coordinated by S. Fillatreau. ARTiDe involves 8 partners providing novel technologies for the systematic identification of autoantigen-specific Tregs and Teffs in humans, the selection of optimal TCR to produce protective Tregs, innovative humanized T1D pre-clinical models to test their efficacy and safety, the development of industrial process for TCR-engineered Treg production, and new Treg supporting strategies in vivo.
This post-doctoral scientist will work on 1) the molecular characterization of autoreactive Teffs and Tregs at single cell level in patients with T1D and control in order to decipher the basis for the loss of immunological tolerance in this human disease, as well on 2) the evaluation of the selected autoreactive TCR obtained through the single cell studies above for their capacity to produce protective Tregs using a novel humanized model for T1D.
INEM is a biomedical research center including 19 teams and two departments: “Cell Biology (Growth and Signaling)” and “Immunology, Infectiology, and Haematology”. Together with the IMAGINE institute and the Hôpital Necker-Enfants Malades, it makes up the Necker campus which, supported by state-of-the-art core facilities, provides a vibrant environment for basic research and translational innovation. The Campus has a long-standing reputation for scientific excellence (8 principal investigators (PIs) at INEM received ERC awards) and key pioneering medical contributions (e.g. transplantation, biotherapy, gene therapy).
The position is funded for a post-doctoral scientist (3 years).
Please send your application via email in English with CV, a brief outline of previous research, and contact details of three references to: simon.fillatreau@inserm.fr ; simonfillatreau@googlemail.com
